Clinical Trial Update: Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid [NA]

View source ↗

Summary

The clinical trial is investigating the IL-17–dependent inflammatory response in Bullous Pemphigoid and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Snippet

Sponsor: CHU de Reims | Conditions: Bullous Pemphigoid | NA | Status: RECRUITING